MisonidazoleNitroimidazolesNeoplasmsAntineoplastic AgentsCell HypoxiaCell Line, TumorRadiation-Sensitizing AgentsEtanidazoleNeoplasms, ExperimentalCell SurvivalRadiation DosageTumor BurdenRadiation, IonizingTumor Markers, BiologicalRadiation ToleranceDose-Response Relationship, RadiationTumor Necrosis Factor-alphaXenograft Model Antitumor AssaysRadiation InjuriesSarcoma, ExperimentalMice, NudeDose-Response Relationship, DrugOxygenAnoxiaTransplantation, HeterologousMammary Neoplasms, ExperimentalNeoplasm TransplantationNeovascularization, PathologicTriazinesCell ProliferationTumor Suppressor Protein p53ApoptosisWilms TumorDrug Screening Assays, AntitumorBrain NeoplasmsDoxorubicinHypoxia-Inducible Factor 1, alpha SubunitFibrosarcomaTime FactorsMaximum Tolerated DoseMice, Inbred BALB CTumor Cells, CulturedColonic NeoplasmsCell DivisionNeoplasm MetastasisGenes, Tumor SuppressorRadiationTumor MicroenvironmentAdenocarcinomaHypoxia-Inducible Factor 1Combined Modality TherapyTreatment OutcomeMice, SCIDDrug Delivery SystemsGene Expression Regulation, NeoplasticTumor Suppressor ProteinsCisplatinAntineoplastic Agents, PhytogenicCarcinoid TumorCell LineAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCarcinoma, Ehrlich TumorSignal TransductionRadiation ProtectionAntibiotics, AntineoplasticDrug Resistance, NeoplasmNeuroendocrine TumorsRNA, MessengerNeoplasm ProteinsCarcinoma, Squamous CellOvarian NeoplasmsLung NeoplasmsRadiation MonitoringDrug Administration ScheduleProdrugsAntigens, NeoplasmAngiogenesis InhibitorsAntibodies, MonoclonalFlow CytometryPaclitaxelLiver NeoplasmsPorfiromycinNitrofuransKidney NeoplasmsDrug SynergismDNA DamageDrug CarriersDNA, NeoplasmImmunohistochemistryCell CycleCamptothecinReverse Transcriptase Polymerase Chain ReactionCells, CulturedMice, Inbred C57BLBlotting, WesternGliomaTissue DistributionPancreatic NeoplasmsNeoplasm Staging